Figure 3 - full size

Figure 3.
Fig. 3. The VIVIT peptide selectively inhibits NFAT activation but not calcineurin activity. (A) The VIVIT peptide did not inhibit calcineurin phosphatase activity, assayed as radiolabel released (counts per minute × 10^ 3) from ^32P-phospho-RII peptide (9). The numbers next to each peptide label indicate peptide concentrations (micromolar). CsA/CypA complexes were used at 10 µM. (B) Selective inhibition of NFAT reporter activity (11). Jurkat cells were cotransfected with 3xNFAT-Luc (left panel) or 2xNF- B-Luc (right panel) reporter plasmid, and with GFP and GFP-VIVIT expression plasmids as indicated (measured in micrograms of plasmid per 10^6 cells). Twenty-four hours after transfection, cells were left untreated (open bars) or were stimulated for 6 hours with PMA and ionomycin (solid bars). (C) Calcineurin dependence of NFAT and NF- B reporter activity in T cells (11). Jurkat cells were transfected with 3xNFAT-Luc (left panel) or 2xNF- B-Luc (right panel) reporter plasmid. Twenty-four hours after transfection, cells were left unstimulated or were stimulated for 6 hours with PMA and ionomycin (P+I) in the absence or presence of CsA. (D) Inhibition of NFAT-dependent activation of the IL-2 and TNF- promoters (11). Jurkat cells were cotransfected with GFP or GFP-VIVIT expression plasmids and with luciferase reporter plasmids driven either by the human IL-2 promoter (left panel) or by the human TNF- promoter (right panel). Twenty-four hours after transfection, cells were left unstimulated (open bars) or were stimulated for 6 hours with PMA and ionomycin (solid bars) or with anti-CD3 and anti-CD28 (hatched bars).